Wyeth in negotiations to acquire Crucell - MarketLine Financial Deals

Wyeth in negotiations to acquire Crucell

Wyeth in negotiations to acquire Crucell - MarketLine Financial Deals
Wyeth in negotiations to acquire Crucell
Published Jan 07, 2009
3 pages — Published Jan 07, 2009
Price US$ 45.00  |  Buy this Report Now

About This Report

  
Abstract:

Wyeth, a US-based company engaged in the discovery, development, manufacture, and sale of pharmaceutical products, is in negotiations to acquire Crucell N.V., a Netherlands-based biopharmaceutical company.

  
Source:
Document ID
MA01177_090109
Country
Country
Ticker
WYE=US
Ticker
CRXL=NL
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Wyeth in negotiations to acquire Crucell" Jan 07, 2009. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Wyeth-in-negotiations-to-acquire-Crucell-2052-1109>
  
APA:
MarketLine Financial Deals. (2009). Wyeth in negotiations to acquire Crucell Jan 07, 2009. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Wyeth-in-negotiations-to-acquire-Crucell-2052-1109>
  
US$ 45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.